Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 31, 2022 16:05 ET | Source: Shockwave Medical, Inc.

Correcting and Replacing: Shockwave Medical to Participate in Two Upcoming Investor Conferences

SANTA CLARA, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat...
August 08, 2022 16:05 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Reports Second Quarter 2022 Financial Results

SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
July 25, 2022 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2022 Results and Participation in Upcoming Investor Conference

SANTA CLARA, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified...
May 23, 2022 07:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy

SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely...
May 19, 2022 08:20 ET | Source: Shockwave Medical, Inc.

Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years

SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
May 19, 2022 07:00 ET | Source: Shockwave Medical, Inc.

Shockwave IVL Coronary Studies Demonstrate Excellent PCI Outcomes in Both Women and Men at One Year

SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
May 09, 2022 16:02 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Reports First Quarter 2022 Financial Results

SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
April 27, 2022 08:00 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2022 Results and Participation in Upcoming Investor Conferences

SANTA CLARA, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified...
March 31, 2022 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Announces Global Launch of New Peripheral Intravascular Lithotripsy Catheter

SANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
March 30, 2022 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL

Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets SANTA CLARA, Calif., March 30, 2022 (GLOBE...